申请人:Takeda Chemical Industries, Ltd.
公开号:EP0255366A2
公开(公告)日:1988-02-03
A compound of the general formula [I]:
wherein R₁ represents a higher alkyl group or an N-(higher alkyl)carbamoyl group, R₂ represents hydrogen, a lower alkyl group, an acyl group having at least three carbon atoms, an N-(lower alkyl)carbamoyl group, an N-(lower alkyl)thiocarbamoyl group or a benzyl group, R represents a primary, secondary or tertiary amino group or a quaternary ammonium group, x is l or 2, y is 0, 1 or 2. and z is an integer of 2-l0, or a pharmaceutically acceptable salt thereof. The novel substances have both anti-tumor activity and platelet activating factor-inhibiting property, and they are effective as an anti-tumor agent without circulatory trouble.
通式[I]的化合物:
其中 R₁ 代表高烷基或 N-(高烷基)氨基甲酰基,R₂ 代表氢、低级烷基、至少有三个碳原子的酰基、N-(低级烷基)氨基甲酰基、N-(低级烷基)硫代氨基甲酰基或苄基,R 代表伯、仲或叔氨基或季铵基,x 为 l 或 2,y 为 0、1 或 2。或其药学上可接受的盐。这些新物质既具有抗肿瘤活性,又具有抑制血小板活化因子的特性,作为抗肿瘤剂效果显著,且不会造成循环障碍。